for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

BRIEF-Kiniksa Announces Lancet Rheumatology Publication Of Clinical Outcomes With Mavrilimumab In Covid-19

June 17 (Reuters) - Kiniksa Pharmaceuticals Ltd:

* KINIKSA PHARMACEUTICALS - ANNOUNCES LANCET RHEUMATOLOGY PUBLICATION OF CLINICAL OUTCOMES WITH MAVRILIMUMAB IN COVID-19

* KINIKSA PHARMACEUTICALS - YESCARTA PHASE 2 TRIAL EXPECTED TO COMMENCE IN H2 2020 Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up